(Q48606849)

13 February 2018

title

Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators. (English)

1 reference

13 February 2018

author name string

Heather B Bradshaw

1

1 reference

13 February 2018

Neta Rimmerman

2

1 reference

13 February 2018

Jocelyn F Krey

3

1 reference

13 February 2018

J Michael Walker

4

1 reference

13 February 2018

publication date

23 March 2006

1 reference

13 February 2018

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

published in

1 reference

13 February 2018

volume

291

1 reference

13 February 2018

page(s)

R349-58

1 reference

13 February 2018

issue

2

1 reference

13 February 2018

Sex differences in pain and hypothalamic-pituitary-adrenocortical responses to opioid blockade

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Strategies and methods for research on sex differences in brain and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

The expanding field of cannabimimetic and related lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Sex differences in behavioral effects of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Endocannabinoids in the central nervous system: from neuronal networks to behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Evaluation and management of endocrine dysfunction in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

An endocannabinoid mechanism for stress-induced analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Sexual dysfunction in women with hyperprolactinemia: a pilot study report

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Estrogen actions throughout the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Prenatal Delta(9)-tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Involvement of prolactin, vasopressin and opioids in post-ictal antinociception induced by electroshock in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

The complexities of the cardiovascular actions of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Anandamide and vanilloid TRPV1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

The effect of anandamide on prolactin secretion is modulated by estrogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Quantitative measurement of depolarization-induced anandamide release in human and rat neocortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

2-Arachidonoylglycerol and the cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Sex differences in antinociceptive and motoric effects of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Identification and functional characterization of brainstem cannabinoid CB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Endocannabinoids in pain modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Pain modulation by release of the endogenous cannabinoid anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

Cannabinoids and neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00933.2005

10.1152/AJPREGU.00933.2005

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

16556899

1 reference

13 February 2018